Our group investigates how drugs affect entire networks of proteins in the body at once to achieve their therapeutic effects, via computational predictions paired with experimental testing.
My research focuses on discovering and characterizing novel small molecules that can control stem cell maintenance, activation, differentiation, and reprogramming in various tissue types.
My research focuses on the development of drug-like molecules that alter important biological processes. These molecules will help us understand human biology and may lead to the design of new drugs.
